Study suggests cutting even a small percentage of foods flagged by Health Canada’s new front-of-package label could translate into heart health benefits.
Semaglutide injection (Ozempic) and oral tablets (Rybelsus) are now both approved to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes.
The problem is especially acute for those with lower health literacy, notes U.S. cardiologist, as experts from both sides of the border call for better education and access to reliable health information.
The position statement released Friday says atherosclerosis—or plaque buildup in the arteries, including cholesterol—starts in childhood and is a key driver of heart disease and stroke.